Abstract |
Diabetic patients have increased levels of advanced glycation end products (AGEs) and the role of AGEs in regulating cancer cell proliferation is unclear. Here, we found that treating colorectal and liver cancer cells with AGEs promoted cell proliferation. AGEs stimulated both the expression and activation of a key transcription factor called carbohydrate responsive element binding protein (ChREBP) which had been shown to promote glycolytic and anabolic activity as well as proliferation of colorectal and liver cancer cells. Using siRNAs or the antagonistic antibody for the receptor for advanced glycation end-products (RAGE) blocked AGEs-induced ChREBP expression or cell proliferation in cancer cells. Suppressing ChREBP expression severely impaired AGEs-induced cancer cell proliferation. Taken together, these results demonstrate that AGEs-RAGE signaling enhances cancer cell proliferation in which AGEs-mediated ChREBP induction plays an important role. These findings may provide new explanation for increased cancer progression in diabetic patients.
|
Authors | Hanbei Chen, Lifang Wu, Yakui Li, Jian Meng, Ning Lin, Dianqiang Yang, Yemin Zhu, Xiaoyong Li, Minle Li, Ye Xu, Yuchen Wu, Xuemei Tong, Qing Su |
Journal | Molecular and cellular endocrinology
(Mol Cell Endocrinol)
Vol. 395
Issue 1-2
Pg. 69-78
(Sep 2014)
ISSN: 1872-8057 [Electronic] Ireland |
PMID | 25111846
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2014. Published by Elsevier Ireland Ltd. |
Chemical References |
- Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
- Glycation End Products, Advanced
- MLXIPL protein, human
- Neoplasm Proteins
- Receptor for Advanced Glycation End Products
|
Topics |
- Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
(biosynthesis)
- Cell Proliferation
- Gene Expression Regulation, Neoplastic
- Glycation End Products, Advanced
(metabolism)
- Hep G2 Cells
- Humans
- Neoplasm Proteins
(metabolism)
- Neoplasms
(metabolism, pathology)
- Receptor for Advanced Glycation End Products
(metabolism)
|